Barak Ben Arye - 03 Mar 2026 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: General Counsel
Signature: Steven Robbins, as attorney in fact for Ben Arye, Barak
Issuer symbol: NVCR
Transactions as of: 03 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2026, 16:32:48 UTC
Previous filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ben Arye Barak	General Counsel	C/O NOVOCURE INC., 1550 LIBERTY RIDGE DRIVE, SUITE 115, WAYNE	Steven Robbins, as attorney in fact for Ben Arye, Barak	05 Mar 2026	0001917165

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Award		+50,125	+26%	$0.000000^*	242,453	03 Mar 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVCR	Stock Option (Right to Buy)	Award		+73,340		$0.000000^*	73,340	03 Mar 2026	Ordinary Shares	73,340	$13.30	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates.
F2	Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.